Using single-cell proteogenomics to fight multiple myeloma
Presently one the organization has willingly volunteered to improve accuracy drug utilizing single-cell examination: Proteome. Among its first targets are blood malignant growths, for example, various myeloma. As one of the most forceful blood tumors, the treatment of different myeloma accompanies various difficulties.
"Myeloma is an extremely troublesome malady to treat since it always backslides," clarifies Chng Wee Joo, Senior Consultant and Head of Department of Hematology-Oncology at the National University Cancer Institute Singapore. "The tumor cells are exceptionally heterogeneous, and the resistant microenvironment likewise assumes a significant job, making extra multifaceted nature. Ordinarily, patients are treated with different medications simultaneously, which triggers reactions and is amazingly exorbitant. There is unquestionably a requirement for better accuracy medication here."